3,000 women surveyed to boost breast cancer early detection
NCT ID NCT07149636
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study surveys 3,000 women aged 40 and older in Chinese communities to understand how aware they are of breast self-exams and how often they do them. Using a health belief model, researchers will look at what factors influence these practices. The goal is to find gaps between knowing and doing, so better education programs can be created to catch breast cancer earlier.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could identify key gaps in breast self-exam knowledge and help design better community education programs to catch breast cancer earlier.
- What could go wrong
- This is an observational survey, not a treatment trial. It only measures awareness and practices, so it cannot directly improve health outcomes or prove that education alone reduces cancer deaths.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 3,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2023
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
This study will recruit community-dwelling women aged approximately 40 years and above from multiple urban and suburban residential areas in Beijing, China. Participants will be permanent residents who have lived in the community for at least 6 months and are able to communicate effectively to complete the survey. The study population represents a diverse range of educational backgrounds, occupations, and health awareness levels. All participants will be enrolled during community-based health education and screening activities, and informed consent will be obtained prior to participation.
- Ages
-
40 to 99 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Self-identified females aged approximately 40 years and older. * Permanent residents of the selected community for at least 6 months. * Able to communicate and understand the survey questions clearly. * Provide informed consent to participate in the study. Exclusion Criteria: * History of breast cancer or other serious breast diseases requiring ongoing treatment. * Cognitive impairment, severe mental illness, or other conditions affecting the ability to answer the questionnaire. * Temporary residents or those planning to leave the community within 6 months. * Refusal to fill out survey.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast neoplasms are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking union medical college hospital
Beijing, 100730, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A Non-Invasive breast scan aims to find the cause of nipple discharge
- Can dancing ease the exhaustion of breast cancer treatment?
- AI reads tumor slides to match cancer patients with trials
- Can a Pharmacist's talk help COPD patients breathe easier and spend less?
- Lung imaging could reveal the best anesthetic dose for breast surgery
- Can a Dual-Target drug crack resistant gynecologic and breast cancers?